Click to Share
 

Regenerative Medicine Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

12536578
By The CHARMED Foundation
The CHARMED Foundation is the first of its kind to support regenerative medicine research specific to pediatric illnesses and sports medicine
12506870
By Blue Horizon International
Brian Mehling, M.D., board-certified orthopedic surgeon and CMO of Blue Horizon International, presents data from “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation" at...
By Stemedica International, SA
Stemedica International, a subsidiary of Stemedica Cell Technologies, Inc.
By AmnioChor Inc.
AmnioChor Inc., an early stage biotech startup based on perinatal stem cell technology, is very pleased to announce that the Musculoskeletal Transplant Foundation of Edison NJ has agreed to invest in their seed round of development of the proprietary...
12470552
By Blue Horizon International
Dr. Mehling, a board-certified orthopedic surgeon and CMO of Blue Horizon International (BHI), will present “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation" at...
By Medical Tourism Association®
Panel Discussion Examines "Innovations in Stem Cell Treatments and Regenerative Medicine," Sept. 20, 2014, in Washington, D.C.
By Blue Horizon Charitable Foundation
Karina C. Tyler is a busy executive assistant who lives and works in New York City. Originally from Brazil, she juggles her limited time between her career, her family, and her passion for sports and travel.
By Carmell Therapeutics Corp.
Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...
12319844
By Xcelthera Inc
Xcelthera Inc Secures First U.S. Patent for Large-Scale Production of High Quality Human Embryonic Stem Cells and their Neuronal and Heart Muscle Cell Therapy Products
By Blue Horizon International
Researchers study the benefits of regenerative medicine in spinal cord injury
By Blue Horizon International
Robert, a 67-year-old physician, who lives in California is an avid outdoorsman who enjoys leading an active lifestyle.
12293379
By South Florida Bone Marrow Stem Cell Trans. Inst.
On March 8 2014, Dr. Dipnarine Maharaj delivered the keynote address for the Annie Appleseed conference in West Palm Beach, FL. The conference featured leading speakers from North America on common and alternative modalities for cancer treatment.
By Blue Horizon International
Broadcaster Jimmy Johnson to Host Segments That Educate Public on Stem Cell Treatments
By Mary Ann Liebert, Inc., publishers
Contact: Sophie Mohin, Mary Ann Liebert, Inc., (914) 740-2100, smohin@liebertpub.com 3D Printing and Additive Manufacturing Preview Issue Publishing Fall 2013 New Rochelle, NY—Mary Ann Liebert, Inc., publishers announces the launch of 3D Printing and...
12057063
By Mary Ann Liebert, Inc., publishers
Stem cells can be grown on biocompatible scaffolds to form complex tissues such as bone, cartilage, and muscle for repair and regeneration of damaged or diseased tissue.
By Eqalix, Inc
WILMINGTON, NC: Eqalix, Inc, an emerging biotechnology company in the Regenerative Medicine space is scheduled to present at the 11th annual BIO Investor Forum in San Francisco at the Palace Hotel.
11891906
By Eqalix, Inc
A trio of tissue engineering technologies developed by researchers and clinicians from Drexel, Penn and CHOP are moving one step closer to becoming viable options for vascular surgery, skin replacement and tissue regeneration.
11701421
By Sarah Bethune Kelly
WA Regenerative Medicine signed a milestone agreement today with University of Southern California, which aims at sharing research, and applying breakthrough medicine to help improve the lives of people in the Greater China Region.

All Press Releases

By charleston sports medicine
Dr. Bright McConnell focuses on regenerative medicine and takes a minimally invasive approach to treatment of injuries at Charleston Sports Medicine. One treatment, Subchondroplasty, may prevent some from undergoing total knee replacement.
By Visiongain
A new report by visiongain predicts that the Translational Regenerative Medicine market will reach $12.1bn in 2020.
12536578
By The CHARMED Foundation
The CHARMED Foundation is the first of its kind to support regenerative medicine research specific to pediatric illnesses and sports medicine
By Charleston Sports Medicine
At Charleston Sports Medicine, Bright McConnell, III, MD combines traditional orthopedics with cutting-edge techniques in regenerative medicine. www.charlestonsportsmed.com.
12506870
By Blue Horizon International
Brian Mehling, M.D., board-certified orthopedic surgeon and CMO of Blue Horizon International, presents data from “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation" at...
By Stemedica International, SA
Stemedica International, a subsidiary of Stemedica Cell Technologies, Inc.
By Shibuya Kogyo Co Ltd
Patent and technical know-how licensing agreement between Yamaguchi University and Shibuya Kogyo, Co. Ltd. for advanced regenerative medicine treatment for liver disease.
By Shibuya Kogyo Co Ltd
Shibuya Announces Business Expansion in Regenerative Medicine Market
By AmnioChor Inc.
AmnioChor Inc., an early stage biotech startup based on perinatal stem cell technology, is very pleased to announce that the Musculoskeletal Transplant Foundation of Edison NJ has agreed to invest in their seed round of development of the proprietary...
By Mary Ann Liebert Inc., publishers
Rapid, large-scale screening to characterize the different subpopulations of multipotent cells that can be derived from fat tissue is an effective strategy to identify and select for specific cell types that would be advantageous for particular...
12470552
By Blue Horizon International
Dr. Mehling, a board-certified orthopedic surgeon and CMO of Blue Horizon International (BHI), will present “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation" at...
By Visiongain
Who are the leading developers and producers of stem cells in 2015, and what are their outlooks? Visiongain’s new study explains A new report by visiongain predicts the world stem cell technology market will generate $13.8bn in 2019, with rapid sales...
By Visiongain
LONDON, UK, 3rd of February 2015: A new report by visiongain calculates that the global translational regenerative medicine market will reach $4.8bn in 2015 with revenues showing growth to 2025.
By Visiongain
Visiongain’s new report predicts the world stem cell technologies market will reach $7.2bn in 2014. The overall industry will earn $12bn in 2018, achieving high revenue growth from 2015 to 2025.
By Regenerative Technology Alliance
RTA, a global provider of standards & certification for the emerging fields of regenerative medicine & science announces the strategic alliance with HHS Registered Institutional Review Board (IRB).
By Medical Tourism Association®
Panel Discussion Examines "Innovations in Stem Cell Treatments and Regenerative Medicine," Sept. 20, 2014, in Washington, D.C.
By Blue Horizon Charitable Foundation
Karina C. Tyler is a busy executive assistant who lives and works in New York City. Originally from Brazil, she juggles her limited time between her career, her family, and her passion for sports and travel.
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, (914) 740-2156, vcohn@liebertpub.com Inner Ear Stem Cells Hold Promise for Restoring Hearing New Rochelle, NY—Spiral ganglion cells are essential for hearing and their irreversible degeneration in the inner ear is common in most...
By Carmell Therapeutics Corp.
Carmell Therapeutics, a company that is developing novel products manufactured from blood plasma, which naturally accelerate the healing of injured tissues, is pleased to announce that it has been awarded a Phase I Small Business Innovation Research...
12319844
By Xcelthera Inc
Xcelthera Inc Secures First U.S. Patent for Large-Scale Production of High Quality Human Embryonic Stem Cells and their Neuronal and Heart Muscle Cell Therapy Products
By Dr. Dennis Lox
Autologous Stem Cells from Teen Soccer Player's Body Were The Key to Healing Her Avascular Necrosis, Saving Her Ankle from Fusion, Which Would Have Ended Her Ability to Play Soccer
By Blue Horizon International
Researchers study the benefits of regenerative medicine in spinal cord injury
By Blue Horizon International
Robert, a 67-year-old physician, who lives in California is an avid outdoorsman who enjoys leading an active lifestyle.
12293379
By South Florida Bone Marrow Stem Cell Trans. Inst.
On March 8 2014, Dr. Dipnarine Maharaj delivered the keynote address for the Annie Appleseed conference in West Palm Beach, FL. The conference featured leading speakers from North America on common and alternative modalities for cancer treatment.
By Blue Horizon International
Broadcaster Jimmy Johnson to Host Segments That Educate Public on Stem Cell Treatments
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn , Mary Ann Liebert, Inc., (914) 740-2100, ext.
By Mary Ann Liebert, Inc., publishers
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
By Mary Ann Liebert, Inc., publishers
Contact: Sophie Mohin, Mary Ann Liebert, Inc., (914) 740-2100, smohin@liebertpub.com 3D Printing and Additive Manufacturing Preview Issue Publishing Fall 2013 New Rochelle, NY—Mary Ann Liebert, Inc., publishers announces the launch of 3D Printing and...
By Florida Spine Center
Stem cells of the future, suffer from knee pain you could be healed with Regenerative Medicine.
By Florida Spine Center
Athletic Performance Enhancing Stem Cells?.... Really? Press Release Tampa, Florida Dennis Lox M.D.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share